JP2024534420A5 - - Google Patents
Info
- Publication number
- JP2024534420A5 JP2024534420A5 JP2024516798A JP2024516798A JP2024534420A5 JP 2024534420 A5 JP2024534420 A5 JP 2024534420A5 JP 2024516798 A JP2024516798 A JP 2024516798A JP 2024516798 A JP2024516798 A JP 2024516798A JP 2024534420 A5 JP2024534420 A5 JP 2024534420A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- haloalkyl
- pharmaceutically acceptable
- tautomer
- stereoisomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163245718P | 2021-09-17 | 2021-09-17 | |
| US63/245,718 | 2021-09-17 | ||
| PCT/US2022/043660 WO2023043923A1 (en) | 2021-09-17 | 2022-09-15 | Cyclic sulfonamide ribonucleotide reductase (rnr) inhibitors and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534420A JP2024534420A (ja) | 2024-09-20 |
| JP2024534420A5 true JP2024534420A5 (cg-RX-API-DMAC7.html) | 2025-08-07 |
Family
ID=85603496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024516798A Pending JP2024534420A (ja) | 2021-09-17 | 2022-09-15 | 環状スルホンアミドリボヌクレオチドレダクターゼ(rnr)阻害剤およびその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250002486A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4401728A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024534420A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240101555A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118434417A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022345092A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3231660A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL311458A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024003258A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202328121A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023043923A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112023002453A2 (pt) | 2020-08-12 | 2023-05-02 | Boundless Bio Inc | Composições de agente de via de estresse de replicação e métodos para tratar câncer |
| EP4587437A1 (en) * | 2022-09-13 | 2025-07-23 | Boundless Bio, Inc. | Cyclic sulfonamide ribonucleotide reductase (rnr) inhibitors and uses thereof |
| EP4770642A2 (en) * | 2023-09-01 | 2026-07-08 | Boundless Bio, Inc. | Ribonucleotide reductase (rnr) compositions and methods of use |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2594799A (en) * | 1998-02-11 | 1999-08-30 | Du Pont Pharmaceuticals Company | Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors |
| WO2016189877A1 (en) * | 2015-05-27 | 2016-12-01 | Kyorin Pharmaceutical Co., Ltd. | Urea derivative or pharmacologically acceptable salt thereof |
| ES2982299T3 (es) * | 2016-05-31 | 2024-10-15 | Taiho Pharmaceutical Co Ltd | Compuestos de sulfonamida o sal de los mismos como inhibidores de ribonucleótido reductasa para el tratamiento del cáncer |
| TWI748142B (zh) * | 2017-11-29 | 2021-12-01 | 日商大鵬藥品工業股份有限公司 | 抗腫瘤劑 |
| AU2018377036B2 (en) * | 2017-11-29 | 2022-04-14 | Taiho Pharmaceutical Co., Ltd. | Sulfonamide compounds and use thereof |
| MA56065A (fr) * | 2019-05-29 | 2022-04-06 | Taiho Pharmaceutical Co Ltd | Polythérapie anticancéreuse mettant en oeuvre un composé de sulfonamide et un immunomodulateur |
| EP4301735A4 (en) * | 2021-03-02 | 2025-05-21 | Boundless Bio, Inc. | Ribonucleotide reductase (rnr) inhibitors and uses thereof |
-
2022
- 2022-09-15 KR KR1020247012612A patent/KR20240101555A/ko active Pending
- 2022-09-15 US US18/692,503 patent/US20250002486A1/en active Pending
- 2022-09-15 CA CA3231660A patent/CA3231660A1/en active Pending
- 2022-09-15 MX MX2024003258A patent/MX2024003258A/es unknown
- 2022-09-15 AU AU2022345092A patent/AU2022345092A1/en active Pending
- 2022-09-15 CN CN202280075394.XA patent/CN118434417A/zh active Pending
- 2022-09-15 EP EP22870692.5A patent/EP4401728A4/en active Pending
- 2022-09-15 TW TW111134951A patent/TW202328121A/zh unknown
- 2022-09-15 IL IL311458A patent/IL311458A/en unknown
- 2022-09-15 JP JP2024516798A patent/JP2024534420A/ja active Pending
- 2022-09-15 WO PCT/US2022/043660 patent/WO2023043923A1/en not_active Ceased